首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Cutting Edge: Persistent Viral Infection Prevents Tolerance Induction and Escapes Immune Control Following CD28/CD40 Blockade-Based Regimen
【24h】

Cutting Edge: Persistent Viral Infection Prevents Tolerance Induction and Escapes Immune Control Following CD28/CD40 Blockade-Based Regimen

机译:前沿:持久性病毒感染可预防基于CD28 / CD40阻断方案的耐受性诱导并避免免疫控制

获取原文
获取原文并翻译 | 示例
           

摘要

A continuing concern with CD28 and/or CD40 blockade-based strategies to induce tolerance and mixed chimerism is their potential to disrupt protective immunity to preexisting infections. In this report, we find that preexisting persistent infection with lymphocytic choriomeningitis virus (LCMV) clone 13 prevents the induction of tolerance, mixed chimerism, and donor-reactive T cell deletion. Mice continue to be refractory to tolerance induction even after viremia has been resolved and virus is presently only at very low levels in peripheral tissues. Conversely, we find that he full tolerance regimen, or costimulation blcokade alone, specifically inhibits already ongoing antiviral immune responses, leading to an inability to control viremia. These findings suggest that ongoing T cell responses continue to depend on costimulatory interactions in the setting of a chronic infection and provide insight into potential risks following costimulation blockade posed by chronic or latent viral infections such as hepatitis C, EBV, and CMV.
机译:基于CD28和/或CD40阻断的诱导耐受性和混合嵌合体的策略的持续关注是它们破坏对先前感染的保护性免疫的潜力。在此报告中,我们发现淋巴细胞性脉络膜脑膜炎病毒(LCMV)克隆先前存在的持续感染可阻止耐受性的诱导,混合嵌合体和供体反应性T细胞缺失。即使病毒血症已经解决,并且小鼠周围组织中的病毒水平目前仍很低,小鼠仍然对耐受诱导没有抵抗力。相反,我们发现他的完全耐​​受方案或单独的共刺激性blcokade可以特异性抑制已经在进行的抗病毒免疫反应,从而导致无法控制病毒血症。这些发现表明,在慢性感染的情况下,正在进行的T细胞反应仍依赖于共刺激相互作用,并提供对由慢性或潜在病毒感染(例如丙型肝炎,EBV和CMV)造成的共刺激阻断后潜在风险的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号